BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 208 filers reported holding BRIDGEBIO PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.6%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $60,317,000 | 40.05% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $308,746,000 | 6.20% |
M28 Capital Management LP | 513,300 | $5,102,000 | 5.33% |
GREAT POINT PARTNERS LLC | 1,050,000 | $10,437,000 | 2.51% |
Octagon Capital Advisors LP | 933,743 | $9,281,000 | 1.60% |
HHLR ADVISORS, LTD. | 5,362,014 | $53,298,000 | 1.40% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $264,613,000 | 1.22% |
Cormorant Asset Management, LP | 1,469,179 | $14,604,000 | 1.02% |
Fernwood Investment Management, LLC | 204,550 | $2,033,000 | 0.86% |
TANG CAPITAL MANAGEMENT LLC | 585,424 | $5,819,000 | 0.71% |